NCT00524745View on ClinicalTrials.gov

Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

NACompletedINTERVENTIONAL
Enrollment

903

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Dose Schedule Study
Interventions
BIOLOGICAL

Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine

Three doses of quadrivalent HPV recombinant vaccine administered at different dosing intervals in each of four study arms.

Trial Locations (1)

Unknown

National Institute of Hygiene and Epidemiology, Hanoi

All Listed Sponsors
collaborator

National Institute of Hygiene and Epidemiology, Vietnam

OTHER

lead

PATH

OTHER

NCT00524745 - Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil | Biotech Hunter | Biotech Hunter